At Daiichi Sankyo UK, we are committed to maintaining the highest standards of integrity and transparency in all our interactions with Healthcare Professionals, Healthcare Organisations, Patient Organisations, Members of the Public, and Journalists. We believe that transparency is fundamental in building trust and fostering positive relationships.
Our disclosure reports are publicly accessible and provide the nature and of our interactions in accordance with The Association of the British Pharmaceutical Industry (ABPI) guidelines. The disclosure is made for Transfer of Value from Daiichi Sankyo for the previous 3 years and presented on an annual basis.
Disclosure of Transfer of Value for Healthcare Professionals and Healthcare Organisations can be found here
At Daiichi Sankyo UK, our motto 'Passion for Innovation. Compassion for Patients extends beyond the development of medicines. Patient centricity is a key component in how we think and work. By better understanding Patient and Caregiver needs, and being sensitive to their care and treatment preferences, we can deliver on Daiichi Sanko’s purpose to enrich the quality of life of people around the world.
At Daiichi Sankyo UK we work with Patient Organisations to support their priorities. In recognising the variety of patient experiences and needs, Daiichi Sankyo aspires to develop more effective healthcare solutions and better outcomes. We do this in a number of ways, including grants, donations and joint initiatives.
For Patient Organisation disclosures please click here.
At Daiichi Sankyo UK, we believe that transparency in all our interactions is fundamental to building and maintaining trust with the communities we serve. Disclosing our engagements with members of the public,patients and journalists is an integral part of this commitment.
For Members of the Public, Patients and Journalists disclosures please click here.
UK/DSC/06/24/0001 - June 2024
